Pathstone Holdings

Pathstone Holdings’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Pathstone Holdings’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-153,846	Closed	-$110K	–	2407
2024 Q1	$110K	Hold	153,846	–	–	﹤0.01%	2218
2023 Q4	$131K	Buy	+153,846	New	+$149K	﹤0.01%	2117

Other funds holding VAXX

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Pathstone Holdings's VAXX Position: Q2 2024 in Review

Pathstone Holdings sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 153,846 shares — an estimated $110K sold.

Pathstone Holdings first reported a position in VAXX in Q4 2023 and held it in 2 quarters. The position peaked at $131K in Q4 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

Pathstone Holdings reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Pathstone Holdings sold 153,846 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $110K.
Pathstone Holdings first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2023 and held it in 2 quarters.
Pathstone Holdings's Vaxxinity, Inc. Class A Common Stock position peaked at $131K in Q4 2023.
8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Pathstone Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.